Will Uber Stock Recover?
Shares of Uber Technologies (NYSE:UBER) have had a rough few…
Buy
60
ATRA Quote, Financials, Valuation and Earnings
Last price:
$15.63
Seasonality move
:
5.9%
Day range:
$15.50 - $17.01
52-week range:
$6.50 - $39.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.97x
P/B ratio:
--
Volume:
72.1K
Avg. volume:
103.2K
1-year change:
19.14%
Market cap:
$95.2M
Revenue:
$8.6M
EPS (TTM):
-$25.76
Atara Biotherapeutics Number of Institutional Trades
Atara Biotherapeutics Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$192.7M
(Last 6 Months)
Current Institutional Ownership Percentage
46.76%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$2.8B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Atara Biotherapeutics Institutional Ownership
-
What Percentage Of ATRA Is Owned by Institutions?
46.76% of ATRA is owned by institutions.
-
How Many Institutions Own ATRA Shares?
Atara Biotherapeutics stock is owned by 199 institutional shareholders at this time.
-
Have Institutions Been Buying ATRA Stock?
Yes, institutions have bought 5.7M shares of ATRA in the last quarter.
-
Have Institutions Been Selling ATRA Stock?
Yes, institutions have sold 131.3M shares of ATRA over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is ARK Next Generation Internet ETF a Good Investment?
The ARK Next Generation Internet ETF looks like a pretty…
Why Is Marvell Stock Up?
Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
44
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
1
IONQ alert for Jan 10
IonQ [IONQ] is up 7.07% over the past day.
Sell
47
CEG alert for Jan 10
Constellation Energy [CEG] is up 25.15% over the past day.
Sell
8
CRNX alert for Jan 10
Crinetics Pharmaceuticals [CRNX] is down 16.31% over the past day.
